American Health Packaging Desmopressin Acetate Tablets Recall

Why it was recalled

GMP Deviations: Product bottle may be absent of desiccant.

Product description

Desmopressin Acetate Tablets, 0.2 mg, 30 tablets (3 x 10 unit dose blister cards), Rx Only, Packaged and distributed by: American Health Packaging, Columbus, Ohio 43217. NDC Carton: 68084-604-21; NDC Unit Dose 68084-604-11

Lot numbers, UPCs & expiration codes

Lot 180510, exp 3/31/2020; Lot 181912, exp 4/30/2020

Where it was sold

Nationwide USA

What to do if you have this product

Compare the lot number and expiration date on your package with the codes above.
Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
If you have symptoms you think are related, contact your doctor. In an emergency call 911.
Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number: D-0849-2020
Classification: Class II
Status: Terminated
Recall initiated: Feb 7, 2020
FDA report date: Feb 26, 2020
Quantity: 3,720 cartons
Recall type: Voluntary: Firm initiated
Recalling firm: American Health Packaging

Original FDA data

Every field from FDA enforcement report D-0849-2020, exactly as published.

Show all FDA fields

City: Columbus
State: OH
Status: Terminated
Country: United States
Event ID: 84990
Address: 2550 John Glenn Ave Ste A
Code information: Lot 180510, exp 3/31/2020; Lot 181912, exp 4/30/2020
Postal code: 43217-1188
Report date: Feb 26, 2020
Product type: Drugs
Recall number: D-0849-2020
Classification: Class II
Recalling firm: American Health Packaging
Product quantity: 3,720 cartons
Termination date: Aug 4, 2022
Reason for recall: GMP Deviations: Product bottle may be absent of desiccant.
Voluntary / mandated: Voluntary: Firm initiated
Product description: Desmopressin Acetate Tablets, 0.2 mg, 30 tablets (3 x 10 unit dose blister cards), Rx Only, Packaged and distributed by: American Health Packaging, Columbus, Ohio 43217. NDC Carton: 68084-604-21; NDC Unit Dose 68084-604-11
Distribution pattern: Nationwide USA
Recall initiation date: Feb 7, 2020
Initial firm notification: Letter
Center classification date: Feb 18, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0849-2020, published Feb 26, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: Oct 2, 2026. Content last changed: Oct 2, 2026.

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.